BioSpace News Archive

Approval is expected within a week, at which point Therma will submit a complete package, including the REB review, to Health Canada to conduct the clinical trial.

Researchers at Children’s Hospital of Philadelphia (CHOP) have identified genes responsible for hematopoietic stem cell (HSC) regeneration via the assembly of the ribosome, the protein factories in cells that translate mRNA sequences into amino acid sequences

VCA Animal Hospitals has named Mars Veterinary Health leader Paola Perez-Loaiza People & Organization Vice President, reporting to VCA president, Todd Lavender, DVM.

Evolugate, LLC, a Gainesville-based biotech company, has demonstrated that its proprietary technology can be used to improve the throughput of plasmid DNA manufacturin

Evolve BioSystems, Inc. today announces that its product, activated B. infantis EVC001, will be used in one of the largest international clinical studies on preventing type 1 diabetes (T1D) in genetically predisposed children.

ZabBio, Inc., announced today that the IND for their first-in-class contraceptive, ZB-06, is active and that the Phase 1 trial is enrolling (ClinicalTrials.gov, NCT04731818).

CLEC-1, novel myeloid immune checkpoint for cancer immunotherapy limiting tumor cells phagocytosis and tumor antigen cross-presentation. BiCKI ® -IL-7, bifunctional therapy targeting PD-1 and IL-7 to sustain exhausted T cell function and to disarm Treg suppressive activity.

Manhattan Scientifics Inc. invested $30 million and a 10-year effort to commercialize the Imagion Biosystems super early, non- invasive, non-radioactive Cancer diagnostic, now “partnered” with MD Anderson Cancer Center, Houston.

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchard, President and Chief Executive Officer and Michael Levitz, Executive Vice President, Chief Financial Officer and Treasurer, will present at the Sidoti Spring Virtual Investor Conference on Thursday, March 25, 2021 at 8:30 a.m. ET.

A recently published, randomized, controlled multicenter study in India shows that urinary catheters with Bactiguard’s coating for infection prevention reduce the risk of catheter-associated urinary tract infections by 69% compared to standard catheters.